October 18, 2021 by Chain Drug Review
Abbott, Jason Sudeikis, Ted Lasso
Supplier News

NEW YORK — Jason Sudeikis, award-winning writer, producer, actor and star of Ted Lasso, is joining Abbott and Real Madrid at an event outside the New York Stock Exchange (NYSE) today. Earlier in the day, Abbott and Real Madrid announced a partnership that will support the health and nutrition of children globally; provide nutritional science for
August 10, 2021 by Chain Drug Review
Abbott, Cardinal Health, COVID-19 tests
Leading Headlines, Pharmacy

DUBLIN, Ohio — Cardinal Health announced on Tuesday its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corp. Cardinal Health will leverage its expansive distribution network to support broad access to Quidel’s QuickVue At-Home OTC COVID-19 Test and Abbott’s BinaxNOW COVID-19 Antigen Self-Test, which allow consumers
June 24, 2021 by Chain Drug Review
Abbott, Harris Poll
Leading Headlines, Supplier News

ABBOTT PARK, Ill. — A new Harris Poll survey finds the majority of adults in the U.S. who exercise intensely understand the importance of maintaining hydration throughout a workout (93%) and that hydration is important for muscle recovery (89%), yet many have misconceptions about the type of hydration that may impact their ability to perform
April 19, 2021 by Chain Drug Review
Abbott, BinaxNOW COVID-19 Ag Self Tes, Robert Ford
Pharmacy, Supplier News

ABBOTT PARK, Ill. — Abbott announced today it began shipping its BinaxNOW COVID-19 Ag Self Test to retailers across the country. Consumers can expect the test to be available in the next few days online and in some stores. Broader nationwide availability is expected in the next two weeks as tests work their way through
March 11, 2021 by Chain Drug Review
Abbott, Abbott Pandemic Defense Coalition
Supplier News

ABBOTT PARK, Ill. — Abbott announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats. By connecting global centers of excellence in laboratory testing, genetic sequencing and public health research, the program will identify new pathogens,
December 22, 2020 by Chain Drug Review
Abbott, Andrea Wainer, COVID-19 vaccines
Leading Headlines, Pharmacy, Supplier News

ABBOTT PARK, Ill. — The development and authorization of a COVID-19 vaccine is a critical scientific milestone in our efforts to combat this pandemic. Abbott released findings on Tuesday from a survey conducted by The Harris Poll, showing that Americans see testing as an essential partner to these new vaccines. Among the key findings: Importance
December 14, 2020 by Chain Drug Review
Abbott, Barbara Marriage, Pedialyte Hydration Solution, Pedialyte with Immune Support
Supplier News

ABBOTT PARK, Ill. — Because supporting the immune system is top of mind for many people, Abbott is launching a new Pedialyte formulation specifically designed with key nutrients to support immune health. Pedialyte with Immune Support was developed for consumers looking for key immune-supporting nutrients in their hydration solution. In addition to an optimal balance
August 31, 2020 by Chain Drug Review
Abbott, Ensure Plus
Supplier News

ABBOTT PARK, Ill. — Abbott announced that Ensure Plus now has 16g of protein, which is 75% more protein than Ensure Original. The company added that it includes essential nutrients to support immune health. By 2050, more than 1 in 5 adults will be over the age of 65. Age and health conditions can often affect weight, strength
August 27, 2020 by Chain Drug Review
Abbott, BinaxNOW COVID-19 Ag Card rapid test for detection of COVID-19 infection, COVID-19, FDA
Leading Headlines, Pharmacy, Supplier News

ABBOTT PARK, Ill. — Abbott announced on Wednesday that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW COVID-19 Ag Card rapid test for detection of COVID-19 infection. Abbott will sell this test for $5. It is highly portable (about the size of a credit card), affordable and provides results
June 29, 2020 by Chain Drug Review
Abbott, diabetes care, insulin delivery systems, John Sheridan, Tandem Diabetes Care
Leading Headlines, Pharmacy, Supplier News

ABBOTT PARK, Ill.— Abbott and Tandem Diabetes Care announced Monday that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott’s world-leading continuous glucose monitoring (CGM) technology with Tandem’s innovative insulin delivery systems to provide more options for people to manage their diabetes. The companies first announced their intention to
May 11, 2020 by Chain Drug Review
Abbott, Emergency Use Authorization (EUA) for the company's SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system., Robert Ford
Pharmacy, Supplier News

ABBOTT PARK, Ill. — Abbott announced on Monday that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system. Abbott plans to ship nearly 30 million antibody tests globally in May across its ARCHITECT and Alinity i platforms and
May 8, 2020 by Chain Drug Review
Abbott, Antibody testing, COVID-19 testing, Robert Ford, University of Washington
Leading Headlines, Pharmacy, Supplier News

ABBOTT PARK, Ill. — Abbott announced on Friday new research, published in the Journal of Clinical Microbiology, which found that its SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began. Independent research was conducted by University of Washington School of
March 29, 2020 by Chain Drug Review
Abbott, coronavirus (COVID-19), ID NOW COVID-19 tests, Robert Ford
Leading Headlines, Pharmacy, Supplier News

ABBOTT PARK, Ill. — Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the
February 19, 2020 by Chain Drug Review
Abbott, bbott's world-leading glucose sensing technology, FreeStyle Libre 2 system, Insulet Corp., Jared Watkin, Omnipod Horizon Automated Insulin Delivery (AID) System
Leading Headlines, Pharmacy, Supplier News, Technology

ABBOTT PARK, Ill. — Abbott and Insulet Corp. announced Wednesday that the companies are partnering to integrate Abbott’s leading glucose sensing technology with Insulet’s next-generation tubeless system, the Omnipod Horizon Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery and care for people living with diabetes. Controlled through an app